Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/contribution-of-mendelian-disorders-to-common-chronic-disease-vxSoKRYu00
References (54)
-
(2002)
Genetics and molecular diagnostic testing. Number 1, July 2002. American College of Obstetrics and Gynecology, 79
-
P. Murphy, G. Petersen, S. Thibodeau, R. Fishel (2000)
Genetic testing for colon cancer: Joint statement of the American College of Medical Genetics and American Society of Human GeneticsGenetics in Medicine, 2
-
Hereditary hemochromatosis; Kujovich JL, Goodnight SH -
J. Walsh, J. Terdiman (2003)
Colorectal cancer screening: scientific review.JAMA, 289 10
-
American College of Obstetrics and Gynecology -
B. Modan, P. Hartge, G. Hirsh-Yechezkel, A. Chetrit, F. Lubin, Uzi Beller, G. Ben-Baruch, Amiram Fishman, J. Menczer, J. Struewing, M. Tucker, S. Wacholder (2001)
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.The New England journal of medicine, 345 4
-
M. King, S. Wieand, Kathryn Hale, Ming Lee, T. Walsh, K. Owens, J. Tait, L. Ford, B. Dunn, J. Costantino, L. Wickerham, N. Wolmark, B. Fisher (2001)
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.JAMA, 286 18
-
T. Rebbeck, H. Lynch, S. Neuhausen, S. Narod, L. Veer, J. Garber, G. Evans, C. Isaacs, M. Daly, E. Matloff, O. Olopade, B. Weber (2002)
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.The New England journal of medicine, 346 21
-
B. Wullen, A. Mühlhöfer, W. Zoller (2001)
[Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer].Zeitschrift fur Gastroenterologie, 39 11
-
S. Kahler (1993)
The Genetic Basis of Common DiseasesJAMA, 270
-
(1998)
Test and Technology Transfer Committee Working Group. ASHG/ACMG Statement. Measurement and use of total plasma homocysteine -
D. Stevanović (1967)
Nevoid basal cell carcinoma syndrome.Archives of dermatology, 96 6
-
W. Grody, J. Griffin, Annette Taylor, B. Korf, J. Heit (2001)
American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation TestingGenetics in Medicine, 3
-
M. Skolnick, T. Frank, D. Shattuck-Eidens, S. Tavtigian (1997)
Genetic susceptibility to breast and ovarian cancer.Pathologie-biologie, 45 3
-
(1996)
Statement on informed consent for genetic research -
H. Järvinen, M. Aarnio, H. Mustonen, K. Aktán-Collán, L. Aaltonen, P. Peltomäki, A. Chapelle, J. Mecklin (2000)
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.Gastroenterology, 118 5
-
S. Hayflick, M. Eiff, Leslie Carpenter, J. Steinberger (1998)
Primary care physicians' utilization and perceptions of genetics servicesGenetics in Medicine, 1
-
W. Knowler, E. Barrett-Connor, S. Fowler, R. Hamman, J. Lachin, Elizabeth Walker, David Nathan (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.The New England journal of medicine, 346 6
-
(2002)
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.Circulation, 106 25
-
Theresa Frezzo, W. Rubinstein, D. Dunham, K. Ormond (2003)
The genetic family history as a risk assessment tool in internal medicineGenetics in Medicine, 5
-
K. Sweet, T. Bradley, J. Westman (2002)
Identification and referral of families at high risk for cancer susceptibility.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 2
-
C. Brekelmans, C. Seynaeve, C. Bartels, M. Tilanus-Linthorst, E. Meijers-Heijboer, C. Crepin, A. Geel, M. Menke, L. Verhoog, A. Ouweland, I. Obdeijn, J. Klijn (2001)
Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 4
-
A. Green (2004)
The Genetic Basis of Common Diseases, 2nd EditionHuman Genetics, 114
-
(1994)
Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition.American journal of human genetics, 55 5
-
(2002)
Genetics and molecular diagnostic testing -
H. Meijers-Heijboer, B. Geel, W. Putten, S. Henzen‐Logmans, C. Seynaeve, M. Menke-Pluymers, C. Bartels, L. Verhoog, A. Ouweland, M. Niermeijer, C. Brekelmans, J. Klijn (2001)
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.The New England journal of medicine, 345 3
-
(1996)
Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 14 5
-
(2000)
Statement on genetic testing for colon cancer. Joint test and technology transfer committee working group -
P. Walsh (2002)
American Cancer Society guidelines for the early detection of cancer.CA: a cancer journal for clinicians, 51 2
-
M. Das, Saha Pk, Y. Mishra (1971)
Ehlers-Danlos syndrome.Journal of the Indian Medical Association, 57 11
-
F. Visco, M. Skolnick (1996)
Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. CommentariesJournal of Clinical Oncology, 14
-
S. Straus, S. Majumdar, F. McAlister (2002)
New evidence for stroke prevention: scientific review.JAMA, 288 11
-
R. Gemmill, James West, F. Boldog, N. Tanaka, Linda Robinson, David Smith, Frederick Li, H. Drabkin (1998)
The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8.Proceedings of the National Academy of Sciences of the United States of America, 95 16
-
S. Straus, S. Majumdar, F. McAlister (2002)
New Evidence for Stroke Prevention -
P. Yoon, M. Scheuner, Kris Peterson-Oehlke, M. Gwinn, A. Faucett, M. Khoury (2002)
Can family history be used as a tool for public health and preventive medicine?Genetics in Medicine, 4
-
I. Amla, G. Gopalakrishna, N. Kannan (1970)
Niemann pick diseaseThe Indian Journal of Pediatrics, 37
-
D. Rimoin (1997)
Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics -
Ya-Fen Peng, Liang‐Kung Chen, Y. Chou, F. Chang, Shinn-Jang Hwang (2020)
Hereditary hemorrhagic telangiectasia.Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 65 12
-
A. Stiskal, M. Schlemmer, I. Riedinger, M. Wimmer (1980)
[Romano Ward syndrome].Padiatrie und Padologie, 15 1
-
(2002)
Heart and stroke statistics—2003 update -
R. Gemmill, Lynne Bemis, Jason Lee, M Sozen, A. Baron, C. Zeng, Paul Erickson, Joan Hooper, H. Drabkin (2002)
The TRC8 hereditary kidney cancer gene suppresses growth and functions with VHL in a common pathwayOncogene, 21
-
R. Bennett, K. Hart, E. O’Rourke, J. Barranger, Jack Johnson, K. Macdermot, G. Pastores, R. Steiner, R. Thadhani (2002)
Fabry Disease in Genetic Counseling Practice: Recommendations of the National Society of Genetic CounselorsJournal of Genetic Counseling, 11
-
L. Acheson, G. Wiesner, S. Zyzanski, M. Goodwin, K. Stange (2000)
Family history-taking in community family practice: Implications for genetic screeningGenetics in Medicine, 2
-
M. Scheuner, Sue-Jane Wang, L. Raffel, S. Larabell, J. Rotter (1997)
Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood.American journal of medical genetics, 71 3
-
J. Friedman, J. Arbiser, Jonathan Epstein, D. Gutmann, S. Huot, A. Lin, B. McManus, B. Korf (2002)
Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task ForceGenetics in Medicine, 4
-
R. Pike (2000)
Technical and clinical assessment of fluorescence in situ hybridization: An ACMG/ASHG position statement. I. Technical considerations: Test and Technology Transfer CommitteeGenetics in Medicine, 2
-
N. Kauff, J. Satagopan, M. Robson, Lauren Scheuer, M. Hensley, C. Hudis, N. Ellis, J. Boyd, P. Borgen, R. Barakat, L. Norton, M. Castiel, K. Nafa, K. Offit (2002)
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.The New England journal of medicine, 346 21
-
Paul Betts, Brenda Mokry, D. Risser, N. Weiss, Melanie Williams, E. Sjoberg, M. Clanton, L. Frankel, L. Foxhall, L. Hancock, A. Henderson, K. Heusinkveld, J. Hornaday, M. Redrow, J. Albano (2004)
Cancer Facts & Figures 2004 -
K. Koscica, J. Canterino, J. Harrigan, Tressie Dalaya, C. Ananth, A. Vintzileos (2001)
Assessing genetic risk: comparison between the referring obstetrician and genetic counselor.American journal of obstetrics and gynecology, 185 5
-
F. Giardiello, J. Brensinger, G. Petersen (2001)
AGA technical review on hereditary colorectal cancer and genetic testing.Gastroenterology, 121 1
-
T. Rebbeck, A. Levin, A. Eisen, C. Snyder, P. Watson, L. Cannon-Albright, C. Isaacs, O. Olopade, J. Garber, A. Godwin, M. Daly, S. Narod, S. Neuhausen, H. Lynch, Barbara Weber (1999)
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.Journal of the National Cancer Institute, 91 17
-
L. Fananapazir (1999)
Advances in molecular genetics and management of hypertrophic cardiomyopathy.JAMA, 281 18
-
Wendy McKinnon, Bonnie Baty, Robin Bennett, Monica Magee, Whitney Neufeld-Kaiser, Kathryn Peters, Jill Sawyer, Katherine Schneider (1997)
Predisposition genetic testing for late-onset disorders in adults. A position paper of the National Society of Genetic Counselors.JAMA, 278 15
-
Susan Klugman
ACOG COMMITTEE OPINIONObstetrics & Gynecology
- Publisher
- Wiley
- Copyright
- "Copyright © 2004 Wiley Subscription Services, Inc., A Wiley Company"
- ISSN
- 1552-4825
- eISSN
- 1552-4833
- DOI
- 10.1002/ajmg.c.30008
- pmid
- 14755434
- Publisher site
- See Article on Publisher Site
Abstract
Recognizing Mendelian disorders should improve health care for persons with strong familial risks for common chronic diseases. The Online Mendelian Inheritance in Man (OMIM) database was reviewed to identify Mendelian disorders featuring 17 common chronic diseases, including 9 cardiovascular conditions, diabetes, and 7 common cancers. Mendelian disorders were selected if any one of the 17 diseases was reported in more than two families manifesting in adulthood. Patterns of chronic diseases and modes of inheritance associated with these Mendelian disorders are described. The GeneTests/Reviews database and other websites were reviewed to determine availability of genetic testing and management and prevention recommendations for the selected disorders. Of 2,592 (OMIM) entries reviewed, 188 Mendelian disorders were selected. Most (67.7%) are autosomal dominant disorders. Almost half (45.8%) feature combinations of the chronic diseases under study. At least one gene is known for 68.8% of the selected disorders, and clinical genetic testing is available for 55% of disorders. Guidelines for management and prevention are available for 33.9% of these, ranging from recommendations for supportive care to guidelines for managing affected persons and screening relatives. Significant clinical heterogeneity exists for Mendelian disorders that might present as strong family histories of common chronic diseases. Recognition of the different combinations of diseases within a pedigree, including mode of inheritance and heritable disease risk factors, facilitates diagnosis of these Mendelian disorders. Genetic testing is available for most disorders, which can further clarify the genetic risk, and for some, recommendations for management and prevention are available. However, evidence‐based guidelines are needed. © 2004 Wiley‐Liss, Inc.
Journal
American Journal of Medical Genetics Part A – Wiley
Published: Mar 15, 2005
Keywords: ; ; ;